HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1672261Generated: October 25, 2026
1,1'-Carbonyldiimidazole → 5-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2',3' dideoxyuridine-5'-triphosphate
https://huagongshe.com/reaction/1672261
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1,1'-Carbonyldiimidazole | HCID 68263 | — |
| Reactant | Tetrabutylammonium pyrophosphate | HCID 22385563 | — |
| Reactant | 5-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2',3'-dideoxyuridine-5'-monophosphate | HCID 60025111 | — |
| Product | 5-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2',3' dideoxyuridine-5'-triphosphate | HCID 86599849 | — |
Reaction Steps
Without being limiting in any way, monophosphate (6) can optionally be formed by treatment of 5-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2′,3′dideoxyuridine (5) with, for example, POCl3. 5-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2′,3′-dideoxyuridine-5′-monophosphate (6) can then optionally be treated with, for example, carbonyldiimidazole (CDI) followed by tetrabutylammonium pyrophosphate (TBAPP) under appropriate conditions to form 5-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2′,3′-dideoxyuridine-5′-triphosphate (7). It will be recognized by one of skill in the art that conversion of 5-(4-(N-trifluoroacetyl-2-aminoethoxy)but-2-yn-1-yl)-2′,3′dideoxyuridine (5) to triphosphate (7) can be accomplished by any method known in the art.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07998706B2 |
|---|
| Source dataset | uspto-grants-2011_08 |
|---|
| ORD ID | ord-eb034e572a3240ca89df4f3570f74beb |
|---|
| Source note | uspto-grants-2011_08 |
|---|